1. Nestlé Health Science
  2. brands
  3. 臨床認證 | 雀巢健康科學

臨床認證 | 雀巢健康科學

臨床認證

擁有豐富臨床研究支持
• 自1990年起， 有超過80項研究數據支持及6,000位以上患者參與研究
• 歐洲腸內腸外營養學會 (ESPEN) A級推薦營養配方(1)
• 美國重症醫學會 (SCCM) 及美國腸外腸內營養學會 (A.S.P.E.N.) A級推薦營養配方(2)
• 醫學臨床研究證明有助提升癌症患者身體抵抗力(3), (4)
• 可顯著增加癌症患者白血球及T 淋巴細胞(5) (T-Cell)
• 癌症治療專用營養配方，同時含精氨酸 (L-Arginine)、核苷酸 (Nucleotides) 及奧美加3魚油 (Omega-3 fish oil)
 
癌症治療專用營養配方-免疫營養

 

• 有效減低電療及化療期間患者身體炎症，減低頭頸癌患者出現口腔黏膜炎的機會
• 根據歐洲腫瘤護理學會指出，接受化療的患者，約有40%會出現口腔黏膜炎，而接受高劑量電療的頭頸癌患者，口腔黏膜炎出現的機會率高達100%。
• 根據臨床研究顯示 (Machon, 2012)，在治療期間進食營養品，只有16%的患者出現第三或第四期的口腔黏膜炎，相對先前其他研究的是約45%。
 
含有3大免疫營養素 -免疫營養

 

  • 精氨酸(Arginine): 提升免疫細胞活性，促進傷口癒合
  • 核苷酸(Nucleotides): 增加免疫細胞數量
  • 奧美加3魚油 (Omega-3 fish oil): 抗炎

 

單靠魚油(EPA)並不足夠，還需讓身體中的T1免疫細胞變得更厲害。研究發現，精氨酸、核苷酸有助增加T1免疫細胞的數量與活性，讓免疫軍隊強大有力，同時還可以提升傷口癒合能力，幫助癌症病人按時完成療程。

深受醫護人員和癌症患者肯定與推薦

 

陪伴癌症患者順利完成療程

 

沖調方法

#根據尼爾森2013年8月至2018年7月於全港超市、藥房及便利店癌症/化療/電療類別專用營養品零售調查報告 ( ©2018尼爾森公司 版權所有)
+速癒素TM營養品由2012年至2018年連續7年榮獲最受醫護人員歡迎健康品牌大獎 (主辦機構: 香港醫護聯盟)
(1) A. Weimanna. ESPEN Guidelines on Enteral Nutrition: Surgery including Organ Transplantation. Jan 2006; 25:224-244
(2) McClave SA et al. JPEN. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:
Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). 2009; 33(3):277-316
(3) Daly JM et al. Enteral Nutrition During Multimodality Therapy in Upper Gastrointestinal Cancer Patients. Annals of Surgery 1995. 211 (4): 327-338.
(4) Braga M et al. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal
resection for cancer. Surgery
2002. 132. 805-814.
(5) Maruyama T et al. Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer.
Nutrition 2011. 27
146–152.
(6) Ochoa JB et al. A rational use of immune enchancing diets: When should we use dietary arginine supplementation? NCP 2004; 19 (3): 216-225.
(7) Zhu X et al. Immunosuppression and infection after major surgery: a nutritional de˜ciency. Crit Care Clin 2010; 26(3): 491-500.
(8) Wu G et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009; 3(0) 153-168.
(9) de Aguilar-Nascimento JE et al. Role of enteral nutrition and pharmaconutrition in conditions of splanchnic hypoperfusion. Nutrition 2010; 26(4): 354-358.
(10) Grimble GK et al. Nucleotides as immunomodulators in clinical nutrition. Curr Opin in Clin Nutr and Metab Care. 2001 4(1):57-64.
(11) Calder PC. Polyunsaturated fatty acids and in°ammation. Prostaglandins. Leukotrienes and Essential Fatty Acids. 2006; 75: 197-202.
(12) Mizock BA. Nutritional support in acute lung injury and acute respiratory distress syndrome. NCP. 2001; 16: 319-328.
(13) Machon C, et al. Immunonutrition before and during radiochemotherapy: Improvement of in°ammatory parameters in head and neck cancer patients. Support
Care Cancer 2012;20:3129-3135
(14) Rubenstein EB, Peterson DE, Schubert M et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal
mucositis. Cancer 2004;100(9 Suppl):2026-46
(15) Stone R, Fliedner MC and Smiet ACM. Management of oral mucositis in patients with cancer. Eur J Oncol Nurs 2005;9 (Suppl 1):S24-32
(16) National Cancer Institute. Common Toxicity Criteria, Version 2.0, DCTD, NCI, NIH, DHHS, March 1998. http://ctep.cancer.gov/protocolDevelopment/electronic_
applications/docs/ctcv20_4-30-992.pdf